← All organizations

Aldagen

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jun 1, 2013

Acquired by Nuo Therapeutics on Feb 9, 2012

Timeline

2000s

Jun 1, 2000
Aldagen— Founded

2010s

Feb 9, 2012
Nuo Therapeutics— Acquired By

Drugs by trial phase (6 distinct, 6 trials)

Phase 3 (1 own, 0 via acquisition)

ald-101

Phase 2 (2 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (8)

NCT01774097CollaboratorPhase 2Jun 1, 2013
NCT01273337Study directorPhase 2Mar 1, 2011
NCT01273337Lead sponsorPhase 2Mar 1, 2011
NCT01003912CollaboratorPhase 1Oct 1, 2009
NCT00654433Study directorPhase 3Mar 1, 2008
NCT00654433Lead sponsorPhase 3Mar 1, 2008
NCT00314366CollaboratorPhase 1Apr 1, 2006
NCT00692926CollaboratorPhase 1Oct 1, 2005

Details

Founded: Durham, NC, US Jun 1, 2000
Last known activity: Jun 1, 2013